Key points are not available for this paper at this time.
BBE with anti-GQ1b antibody has homogeneous features. IVIG is the treatment used prevalently for BBE with anti-GQ1b antibody in Japan.
Share your take
Add a clinician perspective alongside expert commentary.
Yoshikawa et al. (2020) studied this question.